Carbohydrates and cancer

Carbohydrate quality, rather than total carbohydrate intake alone, appears to influence cancer risk. Diets high in refined sugars and low in dietary fiber are associated with metabolic conditions that may promote tumor development, while fiber-rich and plant-heavy dietary patterns are linked to reduced risk for certain cancers, particularly colorectal cancer and possibly ovarian and bladder cancers.

Refined carbohydrates cause rapid rises in blood glucose and insulin, activating the insulin and insulin-like growth factor 1 (IGF-1) signaling pathway. This pathway promotes cell proliferation and inhibits programmed cell death, creating conditions favorable for tumor growth. Chronic elevation of blood glucose also drives oxidative stress and systemic inflammation, two established contributors to carcinogenesis. High fructose intake appears to interact with tobacco carcinogens to modify macrophage metabolism through epigenetic reprogramming, accelerating lung tumor progression in animal models. In the colon, dietary fiber is fermented by gut bacteria into short-chain fatty acids that nourish the colonic epithelium, reduce local inflammation, and may suppress abnormal cell growth. Low-fiber diets disrupt this balance, promoting a pro-inflammatory gut environment. Anthocyanins, pigments found in berries and other deeply colored plant foods, have anti-inflammatory and antioxidant properties that may counteract some of the damage associated with Westernized diets. Glucosinolates from cruciferous vegetables are metabolized to bioactive compounds including sulforaphane and indole-3-carbinol, which have shown chemopreventive activity in laboratory and epidemiological studies.

A large longitudinal analysis using Global Burden of Disease 2021 data found that high fasting plasma glucose was the second most important metabolic risk factor contributing to pancreatic cancer mortality and disability-adjusted life years (DALYs) globally between 1990 and 2021, with significant regional variation (PMID 41995512). A narrative review from New Zealand linked excessive dietary sugar intake, childhood obesity, and impaired glucose metabolism to rising rates of early-onset colorectal cancer, particularly among Maori populations, and argued that metabolic dysregulation may be a central driver of colorectal carcinogenesis (PMID 41990382). A global burden of disease analysis found that low dietary fiber was responsible for a substantial and growing share of colorectal cancer deaths between 1990 and 2021, with significant disparities across regions and age groups (PMID 41824859). A systematic review found that high-anthocyanin diets were associated with lower colorectal cancer risk compared to Westernized dietary patterns, with anti-inflammatory and antitumoral properties proposed as the underlying mechanism (PMID 41766895). A narrative review identified mechanisms by which high dietary sugar promotes bladder cancer cell proliferation, epithelial-mesenchymal transition (a process enabling tumor invasion), and suppression of autophagy, and summarized epidemiological evidence associating sugar-sweetened beverage consumption with bladder cancer risk (PMID 41737225). In a mouse model of lung cancer, co-exposure to tobacco carcinogens and a high-fructose diet markedly accelerated tumor progression through metabolic and epigenetic reprogramming of monocytes (PMID 42003899). A case-control study in Italy found that adherence to healthy plant-based dietary patterns was associated with reduced ovarian cancer risk, while an unhealthy plant-based diet index was not associated with protection (PMID 41683747). A multi-center case-control study found that dietary components associated with ectopic fat accumulation were linked to colorectal carcinogenesis, with myosteatosis (fat infiltration of muscle) acting as a mediating pathway (PMID 41895833).

The strongest and most consistent associations between carbohydrate quality and cancer are seen for colorectal cancer, where both low fiber and high refined sugar intake have been independently implicated. Pancreatic cancer risk also appears elevated in the context of chronic high blood glucose and insulin resistance. Bladder cancer may have a sugar-related inflammatory component. People with obesity, insulin resistance, or type 2 diabetes carry additional cancer risk related to chronically elevated glucose and insulin. Populations consuming predominantly Westernized diets, characterized by high refined sugar, low fiber, and limited vegetables, appear most at risk for diet-related cancer.

Evidence linking carbohydrate quality to cancer risk is primarily observational and epidemiological, with mechanistic support from laboratory and animal studies. Randomized controlled trials testing dietary changes and cancer incidence are scarce because of the long time horizons required. The association between low dietary fiber and colorectal cancer is among the most consistent findings in nutritional epidemiology and is reflected in international dietary guidelines. The association between refined sugar and other cancers is biologically plausible and supported by some epidemiological data, but confounding from overall diet quality, obesity, and physical activity makes it difficult to attribute risk to sugar specifically. Animal model findings on fructose-tobacco interactions are intriguing but not yet confirmed in human populations.

Overall, evidence suggests that diets emphasizing whole grains, vegetables, and dietary fiber, while limiting refined sugars and ultra-processed foods, may reduce the risk of certain cancers, particularly colorectal cancer. These findings align with broader recommendations for metabolic health. The independent contribution of carbohydrate quality to cancer risk, separate from its effects on body weight and insulin resistance, requires further clarification in well-designed human trials.